ВАЖНО! Правила приравнивания журналов, входящих в международные базы данных к журналам перечня ВАК.
Ответ на официальный запрос в ВАК журнала Кардиология.

Preview

Kardiologiia

Advanced search

Daily variability of arterial stiffness of patients with arterial hypertension depending on the category of cardiovascular risk

https://doi.org/10.18087/cardio.2489

Abstract

Purpose. The study of the daily variability of arterial stiffness indicators, depending on the category of cardiovascular risk. 

Materials and methods. The study consistently included patients with essential hypertension who were admitted to the cardiology department of the Volga district medical center from November 1, 2015 to October 1, 2017. The study involved 134 patients with an average age of 52±1 years. Depending on the category of total cardiovascular risk, the patients were divided into 3 groups from I (lowest risk) to III (highest risk). The analysis was carried out on ABPM for 12–14 days (BPLab system of “Peter Telegin” firm). Determined: glomerular filtration rate (GFR), the thickness of the intima-media of the common carotid arteries, analysis of the lipid spectrum. For statistical analysis of clinical and instrumental data, a T-criterion for independent samples was used and an ANOVA analysis was performed. A correlation analysis was performed.

 Results. Patients of group III had the highest level of av. SBP (рI–III =0.010; pII–III =0.020) and mean pulse BP (PBP) (рI–III =0.002; pII–III =0.002), also more unfavorable the indicators cALALx (pI–II=0.025; рI–III =0.004), varAlx (рI–III =0.004) and av. ASI (рI–III =0.034). When comparing the data of patients of groups II and III, adjusted for gender and age, it was found that statistically significant differences between the groups of varPAD (pII–III =0.008), AASI (рI–III =0.043), varAlx (pII–III=0.049), as well as a pronounced tendency for varASI (pII–III=0.050). Markers of target organ damage (TIM, LVML, GFR) were more pronounced in the high-risk group. As the risk group increased, the level of HDL decreased (рI–III =0.002; pII–III I=0.0001), the level of TG increased (рI–III =0.007; pII–III =0.009) and the CA (рI–III =0.015). The total cholesterol level was lower in patients of group III compared to group II (pII–III=0.004). Statistically signifi nt relationships of arterial wall stiffness indicators with age were found: crAlx (0.467, p<0.001), varAlx (0.272, p<0.01), cpASI (0.227, p<0.01), varASI (0.407, p<0.001). In addition, women showed significant correlations of medium and high strength between age and mean values of mean SPD (r = 0.490, p<0.05), varPAD (r=0.540, p<0.05), avAS (r=0.460, p<0.05) and varASI (r=0.620, p<0.05). VarASI and WedSASI were most closely associated with the level of SRSAD and SRPAD. Only cASI was associated with GFR, and only varASI was associated with the parameters of the lipid spectrum (HSLPVP, TG, KA and LVMI. 

Conclusion. The most statistically significant dynamics was observed when evaluating varASI, which varied in the sequence I gr.

About the Authors

E. I. Tarlovskaya
Privolzhsky Research Medical University
Russian Federation

Minin and Pozharsky square 10/1, Nizhny Novgorod 603950



A. A. Merezhanova
Privolzhsky Research Medical University
Russian Federation

Minin and Pozharsky square 10/1, Nizhny Novgorod 603950



References

1. Smirnova M. I., Oganov R. G., Gorbunov V. M., Deev A. D., Andreeva G. F. Masked inefficacy of arterial hypertension treatment: prevalence and predictors. Cardiovascular therapy and prevention. 2011;6:11–7.

2. FilippovE.V.,YakushinS.S.Prevalence of arterial hypertension, management of patients with arterial hypertension and varying degrees of risks of cardiovascular events (a study by MERIDIAN-RO). Meditsinsky sovet. 2013;9:65–9.

3. ESC recommendations on cardiovascular prevention (2016). European Journal of Preventive Cardiology. 2016. Available at: http://medspecial.ru/for_doctors/3/27957/

4. Mancia G. Reappraisal of European guidelines on hypertension management: European Society of Hypertension Task Force document. Arterial Hypertension. 2010; 16 (1):4–42.

5. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. Journal of Applied Physiology. 2008;105 (5):1652–60. DOI: 10.1152/japplphysiol.90549.2008

6. Maroules CD, Khera A, Ayers C, Goel A, Peshock RM, Abbara S et al. Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: the Dallas heart study. Journal of Cardiovascular Magnetic Resonance. 2014;16 (1):33. DOI: 10.1186/1532-429X-16-33

7. Koudryavtcev S, Koudryavtcev S. Validation of the BPLab&reg; 24-hour blood pressure monitoring system according to the European standard BS EN 1060–4:2004 and British Hypertension Society protocol. Medical Devices: Evidence and Research. 2011;193. DOI: 10.2147/MDER.S25800

8. Posokhov I, Konradi A, Shlyakhto E, Mamontov O, Orlov A, Rogoza A. Day-to-day repeatability of the Pulse Time Index of Norm. Medical Devices: Evidence and Research. 2014;29. DOI: 10.2147/MDER.S58507

9. Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications. Canadian Journal of Cardiology. 2016;32 (5):659– 68. DOI: 10.1016/j.cjca.2016.02.070

10. Рекомендации по сердечно-легочной реанимации (AHA, 2015). [Internet 2015. Available at: http://CardioPlaneta.ru/emergency/313-rekomendacii-po-serdechno-legochnoy-reanimacii-aha-2015.html

11. Yturralde RF, Gaasch WH. Diagnostic criteria for diastolic heart failure. Progress in Cardiovascular Diseases. 2005;47 (5):314–9. PMID: 16003646

12. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62 (16):e147–239. DOI: 10.1016/j.jacc.2013.05.019

13. Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH et al. Characteristics, Treatments, and Outcomes of Patients with Preserved Systolic Function Hospitalized for Heart Failure. Journal of the American College of Cardiology. 2007;50 (8):768–77. DOI: 10.1016/j.jacc.2007.04.064

14. Karpov Yu. A. European recommendations on arterial hypertension are the main event of 2007. Russian Medical Journal. 2007. [Internet 2007]. Available at: http://www.rmj.ru/articles/kardiologiya/Evropeyskie_rekomendacii_po_arterialynoy_gipertoniiglavnoe_sobytie_2007_g/

15. Diagnosis and treatment of hypertension. Russian recommendations. [Internet 2010]. Available at: http://skoraya-novotr.ucoz.ru/load/diagnostika_i_lechenie_arterialnoj_gipertenzii_rossijskie_rekomendacii_moskva_2010/1-1-0-1

16. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ et al. Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction. Journal of the American College of Cardiology. 2014;63 (7):636–46. DOI: 10.1016/j.jacc.2013.09.063

17. Mitchell GF, Hwang S-J, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al. Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study. Circulation. 2010;121 (4):505–11. DOI: 10.1161/CIRCULATIONAHA.109.886655

18. Shah S. Review: Heart failure with preserved ejection fraction in African Americans. Ethnicity & Disease. 2012;22 (4):432–8. PMID: 23140073

19. http://scardio.ru/news/nauchnomedicinskie_novosti/opublikovan_proekt_soglasovannogo_mneniya_ekspertov_po_ocenke_arterialnoy_zhestkosti

20. Townsend RR. Arterial Stiffness: Recommendations and Standardization. Pulse. 2016;4 (1):3–7. DOI: 10.1159/000448454

21. Rogoza A, Kuznetsov. Central aortic blood pressure and augmentation index: comparison between Vasotens&reg; and SphygmoCor&reg; technology. Research Reports in Clinical Cardiology. 2012;27. DOI: 10.2147/RRCC.S30994

22. Orlov A, Kotovskaya Y, Kobalava Z. Validation of the integration of technology that measures additional &ldquo; vascular&rdquo; indices into an ambulatory blood pressure monitoring system. Medical Devices: Evidence and Research. 2014;7:91–7. DOI: 10.2147/MDER.S61839

23. Simon AC, Levenson J, Bouthier J, Safar ME, Avolio AP. Evidence of early degenerative changes in large arteries in human essential hypertension. Hypertension (Dallas, Tex.: 1979). 1985;7 (5):675–80. PMID: 4030039

24. 2013 ESH/ESC guidelines for the management of arterial hypertension. Russian Journal of Cardiology. 2014; (1):7–94.

25. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. European Heart Journal. 2006;27 (21):2588–605. DOI: 10.1093/eurheartj/ehl254

26. Wu C, Shlipak MG, Stawski RS, Peralta CA, Psaty BM, Harris TB et al. Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study. American Journal of Hypertension. 2017;30 (2):151–8. DOI: 10.1093/ajh/hpw106

27. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D et al. Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension. JAMA. 2012;308 (9):875. DOI: 10.1001/2012.jama.10503

28. Liao D, Arnett DK, Tyroler HA, Riley WA, Chambless LE, Szklo M et al. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension (Dallas, Tex.: 1979). 1999;34 (2):201–6. PMID: 10454441

29. Takase H, Dohi Y, Toriyama T, Okado T, Tanaka S, Sonoda H et al. Brachial-Ankle Pulse Wave Velocity Predicts Increase in Blood Pressure and Onset of Hypertension. American Journal of Hypertension. 2011;24 (6):667–73. DOI: 10.1038/ajh.2011.19

30. Dernellis J, Panaretou M. Aortic Stiffness Is an Independent Predictor of Progression to Hypertension in Nonhypertensive Subjects. Hypertension.2005;45(3):426–31. DOI: 10.1161/01.HYP.0000157818.58878.93

31. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107 (1):139–46. PMID: 12515756

32. Protogerou AD, Blacher J, Aslangul E, Le Jeunne C, Lekakis J, Mavrikakis M et al. Gender influence on metabolic syndrome’s effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis. 2007;193 (1):151–8. DOI: 10.1016/j.atherosclerosis.2006.05.046

33. Najjar SS, Scuteri A, Shetty V, Wright JG, Muller DC, Fleg JL et al. Pulse Wave Velocity Is an Independent Predictor of the Longitudinal Increase in Systolic Blood Pressure and of Incident Hypertension in the Baltimore Longitudinal Study of Aging. Journal of the American College of Cardiology. 2008;51 (14):1377–83. DOI: 10.1016/j.jacc.2007.10.065

34. The Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: “establishing normal and reference values”. European Heart Journal. 2010;31 (19):2338–50. DOI: 10.1093/eurheartj/ehq165

35. Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR et al. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement from the American Heart Association. Hypertension. 2015;66 (3):698–722. DOI: 10.1161/HYP.0000000000000033

36. Karoly N. A., Dolishnaya G. R., Rebrov A. P. Changes in the parameters of monitoring pressure and arterial stiffness in patients with hypertension and chronic obstructive pulmonary disease, against the background of valsartan treatment. Rational pharmacotherapy in cardiology. 2014;10 (1):25–30.

37. Posokhov I, Kuznetsova T, Korneva V, Bryantseva E, Barkan V, Orlov A et al. The 24-hour pulse wave velocity, aortic augmentation index, and central blood pressure in normotensive volunteers. Vascular Health and Risk Management. 2014;247. DOI: 10.2147/VHRM.S61978

38. Omboni S, Posokhov IN, Rogoza AN. Evaluation of 24-Hour Arterial Stiffness Indices and Central Hemodynamics in Healthy Normotensive Subjects versus Treated or Untreated Hypertensive Patients: A Feasibility Study. International Journal of Hypertension. 2015;2015:1–10. DOI: 10.1155/2015/601812

39. Posokhov I, Kulikova N, Starchenkova I, Grigoricheva E, Evdokimov V, Orlov A et al. The “Pulse Time Index of Norm” highly correlates with the left ventricular mass index in patients with arterial hypertension. Vascular Health and Risk Management. 2014;10:139. DOI: 10.2147/VHRM.S58351

40. Posokhov I, Minyukhina I, Lipatov. Analysis of 24-hour pulse wave velocity in patients with renal transplantation. International Journal of Nephrology and Renovascular Disease. 2013;6:125. DOI: 10.2147/IJNRD.S47011

41. Posokhov I. Pulse wave velocity 24-hour monitoring with one-site measurements by oscillometry. Medical Devices: Evidence and Research. 2013;6:11. DOI: 10.2147/MDER.S42082

42. Ageenkova O, Ageenkova O, Purygina. Central aortic blood pressure, augmentation index, and reflected wave transit time: reproducibility and repeatability of data obtained by oscillometry. Vascular Health and Risk Management. 2011;7:649. DOI: 10.2147/VHRM.S24877

43. Ostroumova O. D., Kochetkov A. I., Kopchenov I. I., Guseva T. F., Bondarets O. V. Stiffness of the vascular wall in patients with arterial hypertension. Systemic Hypertension. 2015;12 (2):43–8.

44. Parati G, Schumacher H. Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan – amlodipine monotherapy and combination. Hypertension Research. 2014;37 (3):187–93. DOI: 10.1038/hr.2013.145

45. Dai H, Lu Y, Song L, Tang X, Li Y, Chen R et al. Visit-to-visit Variability of Blood Pressure and Risk of Stroke: Results of the Kailuan Cohort Study. Scientific Reports. 2017;7 (1). DOI: 10.1038/ s41598-017-00380-9

46. Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016; i4098. DOI: 10.1136/bmj.i4098

47. Moiseeva N. M., Ponomarev Yu. A., Sergeeva M. V., Rogoza A. N. Evaluation of arteries stiffness indicators according to bifunctional 24-hour monitoring of blood pressure and ECG using the BPLab® device. Arterial hypertension. 2007;1 (1):1–5.

48. Lantelme P, Mestre C, Lievre M, Gressard A, Milon H. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension (Dallas, Tex.: 1979). 2002;39 (6):1083–7. PMID: 12052846

49. Avolio A, Butlin M, Liu Y-Y, Viegas K, Avadhanam B, Lindesay G. Regulation of arterial stiffness: Cellular, molecular and neurogenic mechanisms. Artery Research. 2011;5 (4):122–7. DOI: 10.1016/j.artres.2011.10.002


Review

For citations:


Tarlovskaya E.I., Merezhanova A.A. Daily variability of arterial stiffness of patients with arterial hypertension depending on the category of cardiovascular risk. Kardiologiia. 2018;58(11S):47-57. (In Russ.) https://doi.org/10.18087/cardio.2489

Views: 1396


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0022-9040 (Print)
ISSN 2412-5660 (Online)